BCM
MYGN icon

Barometer Capital Management’s Myriad Genetics MYGN Stock Holding History

Barometer Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-166,400
Closed -$7.18M – 183
2015
Q4 		$7.18M Sell
166,400
-16,900
-9% -$714K 0.69% 39
2015
Q3 		$6.87M Buy
+183,300
New +$6.51M 0.85% 31

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Barometer Capital Management's MYGN Position: Q1 2016 in Review

Barometer Capital Management sold out of Myriad Genetics (MYGN) in Q1 2016, closing a stake of 166,400 shares — an estimated $7.18M sold.

Barometer Capital Management first reported a position in MYGN in Q3 2015 and held it in 2 quarters. The position peaked at $7.18M in Q4 2015. 233 funds tracked by Wall St. Rank hold MYGN as of Q1 2016.

  • Barometer Capital Management reported no remaining Myriad Genetics position as of Q1 2016 after selling out during the quarter.
  • Barometer Capital Management sold 166,400 Myriad Genetics shares in Q1 2016, an estimated $7.18M.
  • Barometer Capital Management first reported a position in Myriad Genetics in Q3 2015 and held it in 2 quarters.
  • Barometer Capital Management's Myriad Genetics position peaked at $7.18M in Q4 2015.
  • 233 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2016.

Based on Barometer Capital Management's 13F filing for Q1 2016, filed 9 May 2016.